Parajuli, P.; Lara-Garcia, O.E.; Regmi, M.R.; Skoza, W.; Bhattarai, M.; Kulkarni, A.; Robinson, R.L.
Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center Study. Medicines 2020, 7, 30.
https://doi.org/10.3390/medicines7050030
AMA Style
Parajuli P, Lara-Garcia OE, Regmi MR, Skoza W, Bhattarai M, Kulkarni A, Robinson RL.
Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center Study. Medicines. 2020; 7(5):30.
https://doi.org/10.3390/medicines7050030
Chicago/Turabian Style
Parajuli, Priyanka, Odalys Estefania Lara-Garcia, Manjari Rani Regmi, Warren Skoza, Mukul Bhattarai, Abhishek Kulkarni, and Robert Leonard Robinson.
2020. "Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center Study" Medicines 7, no. 5: 30.
https://doi.org/10.3390/medicines7050030
APA Style
Parajuli, P., Lara-Garcia, O. E., Regmi, M. R., Skoza, W., Bhattarai, M., Kulkarni, A., & Robinson, R. L.
(2020). Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center Study. Medicines, 7(5), 30.
https://doi.org/10.3390/medicines7050030
